anti-egfr/c-met antibody-drug conjugate gen1286
Generic: Anti-EGFR/c-Met Antibody-drug Conjugate GEN1286
anti-egfr/c-met antibody-drug conjugate gen1286: 1 clinical trial tracked.
anti-egfr/c-met antibody-drug conjugate gen1286 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about anti-egfr/c-met antibody-drug conjugate gen1286, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors
Primary endpoint: Number of Participants With Adverse Events (AEs)
Interventionalopen23 enrolledStarted 2024-11Completion 2026-034 sites · United StatesGenmab